Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

SOSV-backed Biotech Firm Cell BioEngines Decides New York Is the Place to Be

NEW YORK, Jan. 13, 2024 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., founded by visionary Dr. Ajay Vishwakarma aiming to turn cancer into a curable disease announced today that the SOSV-backed company will establish its executive headquarters in NYC, a hub for the fast-growing life-science ecosystem across New York state.

In a recent interview at IndieBio New York Demo Day on Sept 13, 2023, Dr. Vishwakarma mentioned that he established the company idea while performing his PhD research at Harvard in Boston, a top tier regional biotech cluster. But to translate actual science concepts to the clinic, he partnered with Mt. Sinai in New York licensing the rights to manufacture and commercialize stem cell and immune cell-based cancer immunotherapy research.

"I have spent most of my adult life in Boston biotech hub and witnessed how life sciences industry can ignite a regional economy. There is a unique desire amongst developers and leaders from New York to emulate and turn the city of New York into biotech innovation hub that rivals Boston and San Francisco. With the right companies working on breakthrough innovations that can anchor R&D lab in New York, this transformation is possible," said Dr. Ajay Vishwakarma, MBA, Founder and CEO of Cell BioEngines, Inc.

"New York/New Jersey has made impressive strides catching up to the longer-established Boston/Cambridge ecosystem. One area of marked improvement is venture capital and remains fifth ($1.84 billion in 2022 and $650 million in Q1-Q2 2023), according to PitchBook. To tot up, on Dec 3, 2023, New York City announced reinstatement of refundable biotech tax credits for emerging companies through 2026 to bolster New York’s life sciences sector. This is a testament to New York State’s dedication to attract new businesses in biotech to locate, invent, commercialize, and produce in New York State," he added.

About Cell BioEngines

Cell BioEngines, Inc., is a clinical-stage biotech company focused on developing 'off-the-shelf' allogenic cell therapies as 'drugs' to turn all cancers into curable diseases. The company leverages its proprietary Stem-SPACE™ platform technology to produce clinical-grade cells at economies of scale. The company’s versatile platform and pipeline allows them to pursue a broad range of cell and gene therapy product candidates in therapeutic areas of interest with high clinical and commercial potential.

Contact
Mark Joubert., J.D.
Chief Legal Officer

Cell BioEngines, Inc.
info@cellbioengines.com 


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.